Industry: Healthcare
Delivery Timelines: Please Contact Sales
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Number of Pages: 188
ID: PMRREP33205
1. Executive Summary
1.1. Global Infectious Disease In-Vitro Diagnostics Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. Parent Market Analysis
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
4.3.3.1. Instruments
4.3.3.2. Reagents
4.3.3.3. Software and Services
4.4. Market Attractiveness Analysis: Product Type
4.5. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Technology
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019 - 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
4.5.3.1. Immunoassay
4.5.3.2. Molecular Diagnostics
4.5.3.3. Microbiology
4.5.3.4. Others
4.6. Market Attractiveness Analysis: Technology
4.7. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Application
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
4.7.3.1. MRSA
4.7.3.2. Clostridium Difficile
4.7.3.3. Respiratory Virus
4.7.3.4. TB and Drug-resistant TB
4.7.3.5. Gonorrhea
4.7.3.6. HPV
4.7.3.7. HIV
4.7.3.8. Hepatitis C
4.7.3.9. Hepatitis B
4.7.3.10. COVID-19
4.7.3.11. Others
4.8. Market Attractiveness Analysis: Application
4.9. Global Infectious Disease In-Vitro Diagnostics Market Outlook: End User
4.9.1. Introduction / Key Findings
4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
4.9.3.1. Point-of-care
4.9.3.2. Central Laboratories
4.9.3.3. Others
4.10. Market Attractiveness Analysis: End User
5. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
6.2.1. By Country
6.2.2. By Product Type
6.2.3. By Technology
6.2.4. By Application
6.2.5. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
6.4.1. Instruments
6.4.2. Reagents
6.4.3. Software and Services
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
6.5.1. Immunoassay
6.5.2. Molecular Diagnostics
6.5.3. Microbiology
6.5.4. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
6.6.1. MRSA
6.6.2. Clostridium Difficile
6.6.3. Respiratory Virus
6.6.4. TB and Drug-resistant TB
6.6.5. Gonorrhea
6.6.6. HPV
6.6.7. HIV
6.6.8. Hepatitis C
6.6.9. Hepatitis B
6.6.10. COVID-19
6.6.11. Others
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
6.7.1. Point-of-care
6.7.2. Central Laboratories
6.7.3. Others
6.8. Market Attractiveness Analysis
7. Europe Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Technology
7.2.4. By Application
7.2.5. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
7.4.1. Instruments
7.4.2. Reagents
7.4.3. Software and Services
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
7.5.1. Immunoassay
7.5.2. Molecular Diagnostics
7.5.3. Microbiology
7.5.4. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
7.6.1. MRSA
7.6.2. Clostridium Difficile
7.6.3. Respiratory Virus
7.6.4. TB and Drug-resistant TB
7.6.5. Gonorrhea
7.6.6. HPV
7.6.7. HIV
7.6.8. Hepatitis C
7.6.9. Hepatitis B
7.6.10. COVID-19
7.6.11. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
7.7.1. Point-of-care
7.7.2. Central Laboratories
7.7.3. Others
7.8. Market Attractiveness Analysis
8. East Asia Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Technology
8.2.4. By Application
8.2.5. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
8.4.1. Instruments
8.4.2. Reagents
8.4.3. Software and Services
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
8.5.1. Immunoassay
8.5.2. Molecular Diagnostics
8.5.3. Microbiology
8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
8.6.1. MRSA
8.6.2. Clostridium Difficile
8.6.3. Respiratory Virus
8.6.4. TB and Drug-resistant TB
8.6.5. Gonorrhea
8.6.6. HPV
8.6.7. HIV
8.6.8. Hepatitis C
8.6.9. Hepatitis B
8.6.10. COVID-19
8.6.11. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
8.7.1. Point-of-care
8.7.2. Central Laboratories
8.7.3. Others
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Technology
9.2.4. By Application
9.2.5. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
9.4.1. Instruments
9.4.2. Reagents
9.4.3. Software and Services
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
9.5.1. Immunoassay
9.5.2. Molecular Diagnostics
9.5.3. Microbiology
9.5.4. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
9.6.1. MRSA
9.6.2. Clostridium Difficile
9.6.3. Respiratory Virus
9.6.4. TB and Drug-resistant TB
9.6.5. Gonorrhea
9.6.6. HPV
9.6.7. HIV
9.6.8. Hepatitis C
9.6.9. Hepatitis B
9.6.10. COVID-19
9.6.11. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
9.7.1. Point-of-care
9.7.2. Central Laboratories
9.7.3. Others
9.8. Market Attractiveness Analysis
10. Latin America Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
10.4.1. Instruments
10.4.2. Reagents
10.4.3. Software and Services
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
10.5.1. Immunoassay
10.5.2. Molecular Diagnostics
10.5.3. Microbiology
10.5.4. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
10.6.1. MRSA
10.6.2. Clostridium Difficile
10.6.3. Respiratory Virus
10.6.4. TB and Drug-resistant TB
10.6.5. Gonorrhea
10.6.6. HPV
10.6.7. HIV
10.6.8. Hepatitis C
10.6.9. Hepatitis B
10.6.10. COVID-19
10.6.11. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
10.7.1. Point-of-care
10.7.2. Central Laboratories
10.7.3. Others
10.8. Market Attractiveness Analysis
11. Middle East & Africa Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
11.4.1. Instruments
11.4.2. Reagents
11.4.3. Software and Services
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
11.5.1. Immunoassay
11.5.2. Molecular Diagnostics
11.5.3. Microbiology
11.5.4. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
11.6.1. MRSA
11.6.2. Clostridium Difficile
11.6.3. Respiratory Virus
11.6.4. TB and Drug-resistant TB
11.6.5. Gonorrhea
11.6.6. HPV
11.6.7. HIV
11.6.8. Hepatitis C
11.6.9. Hepatitis B
11.6.10. COVID-19
11.6.11. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
11.7.1. Point-of-care
11.7.2. Central Laboratories
11.7.3. Others
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. QIAGEN
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Becton, Dickinson and Company
12.3.3. bioMérieux SA
12.3.4. F. Hoffmann-La Roche, Ltd.
12.3.5. Hologic, Inc. (Gen Probe)
12.3.6. Abbott
12.3.7. Quidel Corporation
12.3.8. Siemens Healthineers AG
12.3.9. Bio-Rad Laboratories, Inc.
12.3.10. Danaher
12.3.11. OraSure Technologies, Inc.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
